23andMe Holding Co. (ME)

$0.30 -2.35% $-0.00 Healthcare

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.

$153.73M

Ms. Anne Wojcicki

South San Francisco, CA

Jun 17, 2021

-0.23

$-1.31

2.64

3.03

-110.45%

-1.22

0.59

1.38

2.68

-37.51%

-44.16%

Similar stocks (9)

Thermo Fisher Scientific Inc.

TMO

$611.33 0.73%
Uptrend

Danaher Corporation

DHR

$266.20 0.56%
Uptrend

Agilent Technologies, Inc.

A

$137.20 -0.84%
Neutral

IDEXX Laboratories, Inc.

IDXX

$472.35 0.68%
Downtrend

Illumina, Inc.

ILMN

$124.39 -4.14%
Neutral

Waters Corporation

WAT

$328.84 -0.75%
Uptrend

Guardant Health, Inc.

GH

$23.73 -2.47%
Downtrend

Twist Bioscience Corporation

TWST

$36.72 -8.25%
Downtrend

DermTech, Inc.

DMTK

$0.09 -11.32%
Downtrend

ETF Exposure (18)

Invesco Nasdaq Biotechnology ETF

IBBQ

0.01%

$23.54 -1.09%
Neutral

Invesco FTSE RAFI US 1500 Small-Mid ETF

PRFZ

0.01%

$39.17 -1.73%
Neutral

Schwab U.S. Small-Cap ETF

SCHA

0.0036986083%

$48.38 -1.79%
Neutral

ProShares Ultra Nasdaq Biotechnology

BIB

0.002903678983720862%

$62.27 -2.67%
Neutral

Schwab U.S. Broad Market ETF

SCHB

4.780869e-4%

$62.54 -1.70%
Neutral

iShares Core S&P Total U.S. Stock Market ETF

ITOT

2.9e-4%

$118.26 -1.64%
Neutral

Fidelity Nasdaq Composite Index ETF

ONEQ

0%

$65.88 -2.65%
Neutral

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$48.18 -0.99%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$48.17 -0.99%
Neutral

Vanguard Balanced Index Fund

VBINX

0%

$48.17 -0.99%
Neutral

Vanguard Health Care Index Fund

VHT

0%

$281.39 -0.51%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$129.08 -1.69%
Neutral

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$92.34 -1.71%
Neutral

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$92.32 -1.71%
Neutral

Vanguard Total Stock Market Index Fund

VITSX

0%

$129.67 -1.71%
Neutral

Vanguard Total Stock Market Index Fund

VTI

0%

$266.44 -1.66%
Neutral

Vanguard Total Stock Market Index Fund

VTSAX

0%

$129.65 -1.71%
Neutral

Vanguard Extended Market Index Fund

VXF

0%

$170.15 -1.70%
Neutral